A prospective seroprevalence study in the Catalan population underlines the need to get vaccinated despite having been infected, and confirms that hybrid immunity (vaccination plus infection) is more robust and long-lasting. ...
Sep 15, 2022
3
298
Most research on immunity to the SARS-CoV-2 virus and COVID-19 vaccine development has focused on antibody responses to the spike protein and other viral surface proteins. But antibodies that recognize the virus's internal ...
Jun 24, 2022
0
154
In a population-based surveillance published in the Annals of Internal Medicine, the authors found that myocarditis/pericarditis 0 to 7 days after mRNA vaccination in persons aged 5 to 39 years occurred in approximately 1 ...
Oct 3, 2022
0
83
After a man in Rockland County, New York, became the first patient to contract polio in the United States in nearly a decade, experts such as Dr. Peter Salk—whose late father, Jonas, developed a vaccine for the disease—said ...
Jul 25, 2022
0
17
A study published by The BMJ today provides an up-to-date summary of evidence on the risk of heart inflammation (myocarditis and pericarditis) after mRNA vaccination against the COVID-19 virus.
Jul 13, 2022
0
16
A new Australian study led by SAHMRI and Flinders University has uncovered fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system.
Feb 22, 2023
1
215
The White House on Tuesday held a summit with vaccine makers and scientists as it pushed for "next generation" COVID-19 vaccines that offer broader and more durable protection against the virus.
Jul 26, 2022
0
94
Even though most viruses cause infection directly through mucosal cells, the vast majority of vaccines are administered intramuscularly in a cellular mismatch that doesn't always produce optimum immunity.
Victoria Male, a digestion and metabolism professor at Imperial College London, has published a Perspectives piece in the journal Science addressing reports of COVID-19 vaccines having various impacts on menstruation. In ...
Yale scientists have developed a novel omicron-specific mRNA vaccine that offers superior immune protection against two viral subvariants than standard mRNA vaccines.
Jul 19, 2022
0
315
